Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Federmann

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Human Pathology|October 12, 2014
The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemiaBirgit Federmann, Manuel Abele, David Santiago Rosero Cuesta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2014
Monocyte-induced development of Th17 cells and the release of S100 proteins are involved in the pathogenesis of graft-versus-host diseaseKatharina Reinhardt, Dirk Foell, Thomas Vogl, et al.
Annals of Hematology|March 2, 2017
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantationSebastian P Haen, Christiane Groh, Michael Schumm, et al.
Ebiomedicine|April 7, 2019
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemiaMarcus Matthias Schittenhelm, Bianca Walter, Vasileia Tsintari, et al.
Cancer Immunology Research|January 12, 2018
The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid LeukemiaTina Nuebling, Carla Emilia Schumacher, Martin Hofmann, et al.
Blood|April 23, 2015
High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspiratesIrina Bonzheim, Sabrina Giese, Christoph Deuter, et al.
Haematologica|April 12, 2012
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyBirgit Federmann, Martin Bornhauser, Christoph Meisner, et al.
Haematologica|August 29, 2020
Genetic evolution of <i>in situ</i> follicular neoplasia to aggressive B-cell lymphoma of germinal center subtypeAntonio Vogelsberg, Julia Steinhilber, Barbara Mankel, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2014
Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantationJudith Stift, Hideo A Baba, Elisabeth Huber, et al.
Frontiers in Oncology|April 12, 2024
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusionChristopher Hackenbruch, Jens Bauer, Jonas S Heitmann, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Human Pathology|October 12, 2014
The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemiaBirgit Federmann, Manuel Abele, David Santiago Rosero Cuesta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2014
Monocyte-induced development of Th17 cells and the release of S100 proteins are involved in the pathogenesis of graft-versus-host diseaseKatharina Reinhardt, Dirk Foell, Thomas Vogl, et al.
Annals of Hematology|March 2, 2017
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantationSebastian P Haen, Christiane Groh, Michael Schumm, et al.
Ebiomedicine|April 7, 2019
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemiaMarcus Matthias Schittenhelm, Bianca Walter, Vasileia Tsintari, et al.
Cancer Immunology Research|January 12, 2018
The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid LeukemiaTina Nuebling, Carla Emilia Schumacher, Martin Hofmann, et al.
Blood|April 23, 2015
High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspiratesIrina Bonzheim, Sabrina Giese, Christoph Deuter, et al.
Haematologica|April 12, 2012
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyBirgit Federmann, Martin Bornhauser, Christoph Meisner, et al.
Haematologica|August 29, 2020
Genetic evolution of <i>in situ</i> follicular neoplasia to aggressive B-cell lymphoma of germinal center subtypeAntonio Vogelsberg, Julia Steinhilber, Barbara Mankel, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2014
Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantationJudith Stift, Hideo A Baba, Elisabeth Huber, et al.
Frontiers in Oncology|April 12, 2024
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusionChristopher Hackenbruch, Jens Bauer, Jonas S Heitmann, et al.
Pageof 4